BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Degang Y, Akama T, Hara T, Tanigawa K, Ishido Y, Gidoh M, Makino M, Ishii N, Suzuki K. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages. PLoS Negl Trop Dis 2012;6:e1936. [PMID: 23236531 DOI: 10.1371/journal.pntd.0001936] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Mattos KA, Oliveira VC, Berrêdo-Pinho M, Amaral JJ, Antunes LC, Melo RC, Acosta CC, Moura DF, Olmo R, Han J, Rosa PS, Almeida PE, Finlay BB, Borchers CH, Sarno EN, Bozza PT, Atella GC, Pessolani MC. Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. Cell Microbiol 2014;16:797-815. [PMID: 24552180 DOI: 10.1111/cmi.12279] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
2 Kaur G, Kaur J. Multifaceted role of lipids in Mycobacterium leprae. Future Microbiology 2017;12:315-35. [DOI: 10.2217/fmb-2016-0173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
3 Tanigawa K, Hayashi Y, Hama K, Yamashita A, Yokoyama K, Luo Y, Kawashima A, Maeda Y, Nakamura Y, Harada A, Kiriya M, Karasawa K, Suzuki K. Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells. PLoS One 2021;16:e0249184. [PMID: 33770127 DOI: 10.1371/journal.pone.0249184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ferreira H, Mendes MA, de Mattos Barbosa MG, de Oliveira EB, Sales AM, Moraes MO, Sarno EN, Pinheiro RO. Potential Role of CXCL10 in Monitoring Response to Treatment in Leprosy Patients. Front Immunol 2021;12:662307. [PMID: 34354699 DOI: 10.3389/fimmu.2021.662307] [Reference Citation Analysis]
5 Luo Y, Hara T, Ishido Y, Yoshihara A, Oda K, Makino M, Ishii N, Hiroi N, Suzuki K. Rapid preparation of high-purity nuclear proteins from a small number of cultured cells for use in electrophoretic mobility shift assays. BMC Immunol 2014;15:586. [PMID: 25527077 DOI: 10.1186/s12865-014-0062-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ono K, Furugen A, Kurosawa Y, Jinno N, Narumi K, Kobayashi M, Iseki K. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells. Placenta 2019;75:34-41. [PMID: 30712664 DOI: 10.1016/j.placenta.2018.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Luo Y, Degang Y, Ohtsuka M, Ishido Y, Ishii N, Suzuki K. Detection of Mycobacterium ulcerans subsp. shinshuense DNA from a water channel in familial Buruli ulcer cases in Japan. Future Microbiol 2015;10:461-9. [PMID: 25865187 DOI: 10.2217/fmb.14.152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tanigawa K, Luo Y, Kawashima A, Kiriya M, Nakamura Y, Karasawa K, Suzuki K. Essential Roles of PPARs in Lipid Metabolism during Mycobacterial Infection. Int J Mol Sci 2021;22:7597. [PMID: 34299217 DOI: 10.3390/ijms22147597] [Reference Citation Analysis]
9 Cassirer-Costa F, Medeiros NI, Chaves AT, Lyon S, Coelho-Dos-Reis JGA, Ribeiro-Junior AF, Correa-Oliveira R, Rocha MOC, Gomes JAS. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients. Cytokine 2017;97:42-8. [PMID: 28570932 DOI: 10.1016/j.cyto.2017.05.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Saxena S, Spaink HP, Forn-Cuní G. Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models. Biology (Basel) 2021;10:96. [PMID: 33573039 DOI: 10.3390/biology10020096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 White C, Franco-Paredes C. Leprosy in the 21st century. Clin Microbiol Rev 2015;28:80-94. [PMID: 25567223 DOI: 10.1128/CMR.00079-13] [Cited by in Crossref: 81] [Cited by in F6Publishing: 32] [Article Influence: 11.6] [Reference Citation Analysis]
12 Degang Y, Nakamura K, Akama T, Ishido Y, Luo Y, Ishii N, Suzuki K. Leprosy as a model of immunity. Future Microbiology 2014;9:43-54. [DOI: 10.2217/fmb.13.140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
13 Luo Y, Kiriya M, Tanigawa K, Kawashima A, Nakamura Y, Ishii N, Suzuki K. Host-Related Laboratory Parameters for Leprosy Reactions. Front Med (Lausanne) 2021;8:694376. [PMID: 34746168 DOI: 10.3389/fmed.2021.694376] [Reference Citation Analysis]
14 Gibbs BF, Gonçalves Silva I, Prokhorov A, Abooali M, Yasinska IM, Casely-Hayford MA, Berger SM, Fasler-Kan E, Sumbayev VV. Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity. Oncotarget 2015;6:28678-92. [PMID: 26384306 DOI: 10.18632/oncotarget.5212] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
15 Converse PJ, Tyagi S, Xing Y, Li SY, Kishi Y, Adamson J, Nuermberger EL, Grosset JH. Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. PLoS Negl Trop Dis 2015;9:e0003823. [PMID: 26042792 DOI: 10.1371/journal.pntd.0003823] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
16 de Macedo CS, Anderson DM, Pascarelli BM, Spraggins JM, Sarno EN, Schey KL, Pessolani MC. MALDI imaging reveals lipid changes in the skin of leprosy patients before and after multidrug therapy (MDT). J Mass Spectrom 2015;50:1374-85. [PMID: 26634971 DOI: 10.1002/jms.3708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
17 Libbing CL, McDevitt AR, Azcueta RP, Ahila A, Mulye M. Lipid Droplets: A Significant but Understudied Contributor of Host⁻Bacterial Interactions. Cells 2019;8:E354. [PMID: 30991653 DOI: 10.3390/cells8040354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
18 Lupien A, Vocat A, Foo CS, Blattes E, Gillon JY, Makarov V, Cole ST. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169). Antimicrob Agents Chemother 2018;62:e00840-18. [PMID: 30126954 DOI: 10.1128/AAC.00840-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
19 Polycarpou A, Walker SL, Lockwood DN. New findings in the pathogenesis of leprosy and implications for the management of leprosy. Curr Opin Infect Dis 2013;26:413-9. [PMID: 23982232 DOI: 10.1097/QCO.0b013e3283638b04] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
20 Rodríguez G, Arias V. Giant cells lepromatous leprosy. Diffuse dermatitis with exuberant foreign body giant cells in treated lepromatous leprosy. Biomedica 2019;39:26-31. [PMID: 31529831 DOI: 10.7705/biomedica.v39i4.4493] [Reference Citation Analysis]
21 Naafs B, van Hees CLM, van Ingen J. Mycobacterial (Skin) Infections. In: Ólafsson JH, Hay RJ, editors. Antibiotic and Antifungal Therapies in Dermatology. Cham: Springer International Publishing; 2016. pp. 81-139. [DOI: 10.1007/978-3-319-39424-4_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]